An environment of high glucose concentration stimulates the synthesis of extracellular matrix (ECM) in mesangial cell (MC) cultures. This may result from a similar increase in intracellular glucose concentration. We theorized that increased uptake, rather than glucose concentration per se is the major determinant of exaggerated ECM formation. To test this, we compared the effects of 35 mM glucose on ECM synthesis in normal MCs with those of 8 mM glucose in the same cells overexpressing the glucose transporter GLUT1 (MCGT1). Increasing medium glucose from 8 to 35 mM caused normal MCs to increase total collagen synthesis and catabolism, with a net 81-90% increase in accumulation. MCs transduced with the human GLUT] gene (MCGT1) grown in 8 mM glucose had a 10-fold greater GLUT1 protein expression and a 1.9, 2.1, and 2.5-fold increase in cell myo-inositol, lactate production, and cell sorbitol content, respectively, as compared to control MCs transduced with bacterial f8-galactosidase (MCLacZ). MCGT1 also demonstrated increased glucose uptake (5-fold) and increased net utilization (43-fold), and greater synthesis of individual ECM components than MCLacZ. In addition, total collagen synthesis and catabolism were also enhanced with a net collagen accumulation 111-118% greater than controls. Thus, glucose transport activity is an important modulator of ECM formation by MCs; the presence of high extracellular glucose concentrations is not necessarily required for the stimulation of matrix synthesis. (J.
Introduction
The renal glomerular lesion of human and experimental diabetes mellitus is characterized by glomerular hypertrophy (1, 2) and the deposition of extracellular matrix in the form of diffuse thickening of the peripheral basement membrane and mesangial expansion (3) . The progressive accumulation of matrix in the mesangial areas, and the associated encroachment on neighboring capillaries with loss of filtration surface area, is considered as the main structural lesion responsible for the relentless decline in glomerular function (3, 4) . There is persuasive evidence that this critical change may be the result of an altered mesangial cell (MC)' metabolism involving the extracellular matrix. MCs in tissue culture synthesize proteoglycans, fibronectin, laminin, thrombospondin, and various forms of collagens, primarily type IV and type I (5-7). Therefore, a metabolic derangement of these cells in diabetes resulting in the excessive formation and deposition of these matrix components is a likely determinant of mesangial expansion and glomerulosclerosis.
The knowledge on how extracellular matrix synthesis is controlled in MCs is only fragmentary. It is known that the synthetic activity may be stimulated by very diverse factors, notably the mechanical strain induced by distending forces during glomerular hypertension (8) and the action of TGF-,31 (9) .
In diabetes, an obvious injurious alteration could be the continued presence of an abnormally high concentration of extracellular glucose. Recent evidence in humans (10, 11 ) has confirmed early findings in animal studies (12) (13) (14) indicating that strict control of glycemia with insulin administration or successful pancreas transplantation may delay the onset and slow the progression of the characteristic mesangial matrix expansion. In addition, it has been amply demonstrated that MCs in tissue culture increase the production of fibronectin, laminin, collagen type IV as well as mRNA levels for these matrix proteins when incubated in the presence of supraphysiological concentrations of glucose (7, (15) (16) (17) (18) . Although it has been suggested that the increase in matrix synthesis may be partially due to the osmolar effect caused by high glucose concentrations (18) , most of the evidence accumulated thus far indicates that the change is related to the metabolism of glucose (16, 19, 20) . Glucose enters MCs by a facilitated diffusion process which is independent of insulin action (21). It has, therefore, been proposed that intracellular concentrations of glucose may approach those in the extracellular environment in diabetes (21). High intracellular concentrations of glucose may then increase extracellular matrix formation by activating the polyol pathway, inducing myo-inositol depletion, increasing nonenzymatic glycosylation of proteins, or by generation of the second messengers inositol triphosphate and diacylglycerol followed by transcriptional activation of extracellular matrix genes (20, 22) .
We hypothesized that the glucose-induced stimulation of extracellular matrix formation by MCs may not necessarily require the presence of supraphysiological concentrations of glucose if there is an increased transport and thus, excessive bioavailability of this hexose as substrate for metabolism. Except for unique tissues in which glucose is concentrated by an active process involving Na+/glucose cotransporters, i.e., renal proximal tubule and intestinal epithelial cells, glucose enters cells by the passive process of facilitated diffusion. In this process, specific integral membrane proteins, identified as the GLUT family, transport glucose down a concentration gradient. Preliminary work on the identification of glucose transporters in MCs suggests that GLUT1 may be the preponderant isoform (23, 24) . This transporter, considered to be responsible for constitutive transport, is known to be regulatable in some tissues. It is also the most ubiquitously distributed of the GLUT isoforms in vivo, and is expressed in virtually all cultured cells (25) . The high affinity of GLUTI for glucose (26, 27) ensures that this transporter functions at, or close to, its Va, under normal physiological and diabetic hyperglycemic conditions. In MCs, saturation of glucose uptake has been reported at the 30-35 mM level (21). Therefore, enhanced glucose uptake through GLUTI may possibly be achieved by raising its extracellular concentration up to -30 mM, by increasing the intrinsic activity of the transporter (28) , or through stimulation of GLUTI expression and/ or translocation from intracellular sites to the plasma membrane (29) . However, it has not been determined in MCs if enhanced GLUTl-mediated transport per se is associated with an increased utilization of substrate, i.e., whether transport activity may be an important modulator of glucose metabolism.
To test our hypothesis, we compared the production of extracellular matrix in rat MCs exposed to high glucose concentrations with that in the same cells exposed to physiological levels of extracellular glucose, but overexpressing GLUTI protein.
The results herein reported differentiate the effects of extracellular glucose concentration from those of enhanced intracellular glucose availability and utilization on extracellular matrix formation, providing new insights into the pathogenesis of the glomerular lesion of diabetes.
Methods
Materials. The purified extracellular matrix components utilized as standards included rat collagen type I (Upstate Biotechnology Inc., Lake Placid, NY), murine collagen type IV, murine laminin (both from Collaborative Research, Inc., Bedford, MA) and rat fibronectin (Chemicon International, Inc., Temecula, CA). The antibodies used were polyclonal anti-rat collagen type I, anti-rat fibronectin, and anti-mouse collagen type IV (Chemicon International, Inc.), and anti-murine laminin (Collaborative Research, Inc.). The polyclonal, rabbit anti-rat GLUTI antibody used in the identification of GLUTI was generated to specifically react with a 13 amino acid carboxy terminal peptide of this transporter isoform. The latter were obtained from East Acres Biologicals (Southbridge, MA). The affinity-purified, goat anti-rabbit IgG conjugated to 4-nm gold particles and the silver enhancement system IntenseSE' used for the localization of GLUTI at the light microscopic level, were obtained from Amersham Life Sciences Co. (Little Chalfont, United Kingdom). A monoclonal rabbit anti-rat Ig was used in the immunoblotting analysis of 61-tubulin (Sigma Chemical Co., St. Louis, MO).
The human GLUTI cDNA (vector pSPGT) (30) (29) . 50 ,g of solubilized protein samples were separated by SDS-PAGE and electrophoretically transferred to Hybond-ECL nitrocellulose membranes (Amersham Corp., Arlington Heights, IL). As primary antibody, the rabbit anti-rat GLUT1 antibody described above was used. The secondary antibody was a horseradish peroxidase anti-rabbit-Ig conjugate (Amersham Corp.). Antigens were identified by a chemiluminescence assay based on the luminol reaction (ECL Western Blot kit, Amersham Life Sciences; Amersham Corp.). Immunoblotting of /3-tubulin was used as a confirmatory method to assure the equal sample loading between gel lanes. Identification of GLUT1 bands was confirmed by preadsorption of anti-GLUTI antiserum with 25 pg/ml of the purified GLUT1 peptide.
Measurement of production of extracellular matrix components; ELISA. In experiments in which specific extracellular matrix components were studied, production was quantified as the total amount accumulated in the tissue culture medium during 24 h of incubation. At the start of this period, growth medium was changed to one in which NuSerum was replaced by 1% FCS. The presence of Nu-Serum or greater concentrations of FCS were found to result in increased backgrounds and reduced sensitivity of the ELISA. Removal of all serum during the collection period resulted in low recovery rates (3% or less) of added purified extracellular matrix components. Under the conditions used, recoveries were between 62 and 96% of added purified extracellular matrix components (ECM). The amount of specific ECM components secreted into the culture medium was quantified by ELISA, using a modification of a procedure previously described (8) . Samples of culture medium (50-100 p1) were added in triplicate to wells of a 96-well ELISA plate (Falcon Labware, Lincoln Park, NJ) and incubated for 18 h at 4°C. Purified matrix components, diluted in the same medium, were added (0.5 ng-1 ag/well) to each assay plate as standards. At the end of this incubation period, the medium was removed, and the unoccupied sites blocked by a 2-h treatment with 5% nonfat dry milk (Carnation Co., Los Angeles, CA) in PBS containing 0.05% Tween.
Wells were then washed and incubated for 3 h with 100 MI of rabbit antisera for specific extracellular matrix components. All antisera were tested for specificity, before their use, by immunoblotting, with and without blocking, using the extracellular matrix standards described above. After extensive washing of the wells, an enzyme-linked alkaline phosphatase-labeled goat anti-rabbit IgG (Organon Teknika, Durham, NC) was added and the plates were incubated for an additional 3-h period. This was followed by extensive washing and the addition of a phosphatase substrate solution (Sigma Chemical Co. hydroxyproline as an internal standard. These purified amino acids were subsequently analyzed for measurement of '4C incorporation into proline and hydroxyproline. The second method was based on the amount of total '4C incorporated into collagenase-digestible protein (37) . In this method, after completion of the radiolabeling period, 1 ml of medium was mixed with 330 pl of a proteinase inhibitor solution (providing per milliliter: 3 pmol PMSF, 0.1 mmol EDTA, 40 ,umol N-ethylmaleimide).
Medium protein was precipitated and the pellet washed five times with cold 10% TCA. This precipitate was then resuspended in 1 N NaOH, incubated for 10 min at 37°C, and the solution neutralized with 1 N HCl. After adjusting the pH to 7.5 with 1 N Tris buffer solution, PMSF and N-ethylmaleimide were added in the same amounts as before, and CaCl2 added to provide a final 5 mM solution. For enzymatic digestion, the sample was divided into two equal portions and 140 U/ml of collagenase added to one of them, while the other was used as a control. After incubation for 2 h at 37°C, the undigested protein was removed by precipitation with 10% TCA and 0.5% tannic acid. Finally, the '4C radioactivity in the supernatants and protein precipitate was measured and the radiolabel incorporation into collagenase-digestible and collagenase-resistant protein determined from the difference between the treated and nontreated samples.
Immediately after addition of 0.2 N perchloric acid, cell layers were scraped, briefly homogenized in the cold and the precipitates and acidsoluble supernatants separated by centrifugation. To measure the proline endogenous pool, these supernatants were neutralized at 40C with 1 (8) . The cell layer's perchloric acid precipitate was lipid-extracted and consecutively subjected to alkaline and acid hydrolysis for the measurement of total RNA, DNA, and the separation of protein (38) . The final protein precipitate was hydrolyzed as described above, [3H]hydroxyproline internal standard added, and amino acids purified and separated for the quantitation of 14C incorporation into proline and hydroxyproline.
Measurement of 2-deoxyglucose uptake rates and kinetics. The uptake of glucose was determined by using the nonmetabolizable analog 2-deoxy-D- [1-3H] (Fig. 3) . The level of GLUTI mRNA increased 18-fold in MCGT1 cultured in the same conditions. MCLacZ also expressed the glucose transporter protein, as demonstrated by immunogold localization and immunoblot analysis (Figs. 4 and 5) . As compared to these controls, MCGT1 cells cultured in the same glucose concentration demonstrated a 10-fold enhanced expression of GLUTI protein that was evident in immunoblotting analyses (Figs. 5 and 6) and in immunogold studies (Fig. 4) . The latter also demonstrated that this change was generalized and of a similar magnitude in all the MCGT1 cells. In addition, this overexpression was still present at similar levels after 3 mo in cultures maintained in the same normal glucose concentration, as demonstrated by immunoblot analysis (data not shown).
Glucose transport and kinetics. Preliminary experiments demonstrated that, under the conditions selected, 2-deoxyglucose uptake increased linearly with time over the first 10 min of incubation. As compared to the MCLacZ controls, the 5-min uptake of the glucose analog in MCGT1 cells was markedly augmented (Fig. 7) , suggesting a greatly enhanced entry of glucose in cells overexpressing GLUT1. In support of these findings, kinetic analyses revealed a 4.3-fold higher V., in MCGT1 vs MCLacZ cells (P < 0.001) (Fig. 8) . In addition, the Km values for the rat (MCLacZ) and human (MCGTl) transporters were similar (P > 0.2) and within the expected range of values (Fig. 8) .
Cell growth. Exposure of normal MCs to 35 mM glucose for 7 d resulted in a moderately diminished proliferating activity and slight cell hypertrophy, as shown by a 17% significantly lower DNA content and an 8% significantly higher RNA/DNA ratio in cells cultured in high glucose concentration (Table I) hanced glucose transport, albeit these changes were greatly magnified.
Metabolic characteristics. To determine if the enhanced glucose uptake induced by the overexpression of GLUTI transporter was also associated with an increased metabolism of the hexose, lactate and sorbitol contents were measured as indices of substrate utilization. Under the same conditions of normal glucose concentration as above, lactate release into the medium as well as that associated with the cell layer were 2.5-and 2.2-fold greater, respectively, in MCGT1 cultures than in their MCLacZ counterparts (Table II) . In similar experiments, cell sorbitol content was also increased 2.1-fold in MCGT1 cultures (Table II) . Interestingly, this sorbitol accumulation was also associated with a significantly increased content of cell myoinositol (Table II) . These findings suggest that an increased glucose transport in MCs is linked to the greater metabolism of this sugar, at least via the glycolytic and polyol pathways.
Production of extracellular matrix components. The secretion into the medium of specific extracellular matrix components was studied in MCGT1 cells to establish whether enhanced glucose transport, albeit in an environment of normal glucose concentration, could effectively stimulate the synthesis of the main components of mesangial matrix. As compared to their MCLacZ controls, MCGT1 cells secreted significantly a 38% higher RNA/DNA ratio than their MCLacZ controls (Table I ). The lower proliferative activity of the MCGT1 cultures as compared to MCLacZ cultures was also suggested by the different shape of the growth curves obtained over a 15-d period of culture (Fig. 9) . Therefore, the inhibition of replication and hypertrophic effects associated with exposure of normal MCs to high extracellular glucose concentrations were also present under normal glucose concentration in cells with en- more collagen type I, collagen type IV, fibronectin, and laminin ( Fig. 10) .
Northern analyses for individual matrix components demonstrated fibronectin mRNA as a single band and collagens I and IV as their characteristic doublets (46, 47) . Differences in the secretion of extracellular matrix components likely resulted from increased synthesis in MCGT1 cells because their respective mRNAs were elevated 43-80% as compared with their MCLacZ controls (Fig. 11) .
Collagen (Table  HI) . This change was associated with an 80-90% greater net accumulation of newly formed collagen in the medium, as measured by two independent radiolabeling methods. There was an inverse relationship between the amount of DNA in the sample and collagen accumulation (P = 0.0005). When the effect of different DNA content was removed by analysis of covariance, 12 - the differences between groups were still significant (P = 0.0001). In addition, the accumulation of collagen in the cell layer (much lower than into the medium due to the presence of /3-aminopropionitrile) was also increased by 68%. The increment in collagen synthesis caused by glucose was also associated with a 59% greater catabolism. Although the fraction of the collagen produced undergoing catabolism was significantly lower in high glucose concentration cultures, comparison of the magnitude of the changes in synthesis and catabolism reveal that the main cause for net collagen accumulation was enhanced formation.
The increase in collagen accumulation in the incubation medium coincided with a stimulation in overall protein secretion as measured by the two radiolabeling methods (Table III) (collagenase-resistant protein: 8 mM, 42.6±1.4, n = 8; 35 mM, 79.5±3.9 nmol proline/mg DNA/24 h, n = 8, P < 0.0001). However, the change in collagen formation was significantly greater than that for total protein (Table III) .
At the completion of the labeling period, medium proline sp act did not differ in the two groups of transduced cells cultured in 8 (Table IV) . As in experiments in normal mesangial cells, there was a significant effect of the sample's DNA content on the collagen accumulated (P = 0.005). After this effect was eliminated in an analysis of covariance, the differences between groups were still significant (P = 0.015). This augmented collagen accumulation in the medium was part of an overall enhancement in protein synthesis as suggested by results from the two methods used in this study (Table IV) (collagenase-resistant protein: MCLacZ, 45.6±13.3, n = 6; MCGT1, 82.8±10.7 nmol proline/mg DNA/24 h, n = 6, P = 0.055). Nevertheless, as shown above in normal cells, the synthesis of collagen was particularly stimulated in MCGT1 cells (Table IV) . The amount of collagen accumulated in the cell layer was also increased in MCGT1 cells by 64% of the value for MCLacZ cells. Also, as shown in normal MCs, the greater collagen synthesis in MCGT1 cells was associated with a marked increase in collagen catabolism. However, the fraction of collagen produced which was catabolized was similar in both types of cells, therefore, the net collagen accumulation demonstrated in medium and cell layer of MCGT1 cultures was fully attributable to an increased rate of synthesis. Medium was regularly changed at 48-h intervals during the period of cell growth. Subsequently, during the 3-d proline radiolabeling period, without replenishment of the medium, the MCGT1 cells demonstrated a 42-fold greater net glucose utilization (Table IV) , which caused a decrease in the medium glucose concentration from 8 mM to values -5 mM.
Discussion
In this work we have demonstrated that MCs overutilizing glucose synthesize and accumulate increased amounts of extracellular matrix even in the absence of elevated extracellular glucose concentrations. Clearly, it can be concluded from this finding that changes directly related to the presence of a high glucose concentration, i.e., extracellular hyperosmolarity and abnormally increased transmembrane gradients of glucose, are not necessarily required for the excessive formation of extracellular matrix by MCs in a diabetic milieu. This study suggests, instead, that the relevant factor is linked to metabolic changes occurring during the overutilization of glucose which follows its enhanced uptake. MCGT1 cells demonstrated a markedly increased transport of a glucose analog which was due to an increased V,.
while affinity of the transporter remained unchanged. The measured Km in MCGT1 cells and in their MCLacZ controls of 3.1-3.7 mM is consistent with the values of 1-7 mM determined by similar 2-deoxyglucose uptakes in multiple tissues for GLUTM (48, 49) . In conditions of 8 mM glucose concentration, this transporter is, thus, fully saturated and any increases in uptake are expected to be mediated by the up-regulation of transporters. This suggests that under conditions of high glucose concentrations exaggerated glucose uptake and increased extracellular matrix synthesis may be related to increased expression of functional GLUT1.
The increased glucose uptake in MCGT1 cells was also accompanied by a high net utilization of glucose and an exaggerated formation of lactic acid and sorbitol. In addition, it was also associated with the accumulation of myo-inositol. Therefore, alterations related to myo-inositol depletion may be excluded as causative factors for the glucose-stimulated extracellular matrix formation. The facilitative transporters involved in the energy-independent uptake of glucose comprise a group of integral membrane proteins, GLUTI -GLUT5, and GLUT7, which are encoded by separate genes. These proteins transport glucose with different efficiencies and kinetics (27) . GLUT6 is a pseudogene, GLUT7 functions in the endoplasmic reticulum membrane, and GLUT5 is primarily an intestinal fructose transporter. The remaining GLUT isoforms, involved in the cellular transport of glucose, are expressed differently within tissues demonstrating distinct metabolism of this hexose, suggesting a close link between specific transporters and the handling of glucose through specific metabolic pathways (26) . The insulin-regulatable GLUT4 isoform has been identified in MCs (50), however, its functional role remains in doubt since glucose transport and extracellular matrix synthesis in these cells do not appear to be influenced by insulin (20, 21) . In this study, we confirm previous observations in tissue cultures and in renal histological specimens (23, 24) demonstrating the presence of GLUTI in MCs.
To enhance glucose uptake we augmented the transport capacity by increasing the number of transporters. To this end, we transduced the neoR gene encoding neomycin phosphotransferase and human GLUTI or bacterial LacZ (as control) in a cloned line of rat MCs. The resultant MCGT1 cells demonstrated a marked increase in GLUTI synthesis as shown by the overexpression of GLUTI mRNA and GLUTI protein. The overexpression of LacZ or GLUTI in the G418-resistant surviving clones was generalized to all cells and well maintained after multiple passages in culture. In cells such as 3T3-Ll adipocytes in which GLUTI intrinsic activity appears to be modulated, the heterologous expression of human GLUTI is also subject to the same inhibitory control (51) . Therefore, it is expected that if the activity of the endogenous GLUTI were regulated in MCs, the additional exogenous GLUTI transporters expressed in our transduced cells would be under the same form of control.
The effect of high glucose concentrations on MC growth in tissue culture has been variously reported as being neutral ( 16, 21) or exerting inhibitory effects (18, 52) . We observed decreased proliferation and cell hypertrophy in cultures of normal MCs exposed to 35 mM glucose, according to the DNA and RNA/DNA values obtained at the end of the experimental period. Similar growth characteristics were demonstrated in a normal glucose environment by MCs overexpressing the GLUTI transporter when compared to their LacZ-transduced controls. The mechanism by which this enhanced glucose uptake, whether elicited by increasing the extracellular concentration or by stimulating transport, may affect MC growth is not fully understood. However, it is likely that the process involves the induction of endogenous TGF-f31 expression and/or activation (53) . In long term cultures of MCs, high glucose concentrations stimulate TGF-/31 secretion and cause sustained inhibition of cell proliferation, cell hypertrophy and increased protein synthesis (53, 54) . These changes are prevented by neutralizing antibody against TGF-/3 and they are not reproduced in an hyperosmolar environment obtained by the addition of L-glucose or mannitol (53) .
We observed an increased cellular content of myo-inositol concomitant with the augmented glucose uptake and sorbitol accumulation in MCGT1 cells. This is an alteration similar to that seen in cells exposed to high glucose concentrations in which the Va. of the Na + -dependent myo-inositol cotransporter is increased (55, 56) . Although the precise mechanism for this effect has not been elucidated, it involves stimulation of the polyol pathway and activation of protein kinase C. These two metabolic alterations are likely to be present in our MCGT1 cells (see below).
As shown in previous studies (7, (15) (16) (17) 21 ), high concentrations of extracellular glucose increased net formation of collagen in the medium and in the cell layer in MC cultures. In addition, as demonstrated by others (7, 16), we identified an enhanced synthetic rate as the major metabolic alteration responsible for the accumulation of collagen. Contrary to other studies (15) , however, we have observed associated changes in collagen catabolism and total protein synthesis. Collagen catabolism was accelerated by glucose, but this change was of insufficient magnitude to offset the markedly increased synthesis. In addition, protein secretion into the culture medium was also increased, although this change was of lesser magnitude than that for the accumulation of collagen. A possible cause for these discrepant results may be that, contrary to previous work, incorporation results in this study were corrected for changes in the sp act of the amino acid precursor.
The collagen metabolic changes shown in MCGT1 cells incubated in normal glucose conditions qualitatively mirrored those observed in normal MCs exposed to high glucose concentration. However, when compared to their corresponding controls, MCGT1 cells exhibited a greater increase in total collagen synthesis (109 vs 69%) and in collagen accumulation (111-117% vs 81-90%) than normal MCs incubated in high glucose conditions. All four of the individual matrix components examined in the culture medium, collagen I, collagen IV, fibronectin, and laminin, were increased 2.3-to 4.3-fold over values in MCLacZ cultures. In addition, the increased mRNAs for collagen I, collagen IV, and fibronectin is consistent with the increased synthesis of these individual matrix components. Total protein secretion was also enhanced, although not to the same extent as for collagen accumulation. Therefore, in terms of growth characteristics, myo-inositol accumulation and collagen metabolism, MCs overexpressing the GLUTI transporter in an 8 mM glucose environment behaved like normal MCs grown in 35 mM glucose.
Recent studies have begun to unravel the mechanisms by which an increased entry of glucose into MCs may stimulate extracellular matrix formation. MCs grown in a high ambient glucose concentration demonstrate activation of protein kinase C as a result of increased diacylglycerol mass (21, 57). It has been proposed that protein kinase C modulates activator protein 1 complex (AP-1), the transcriptional product of jun and f os protooncogenes, which in turn, binds to specific sequences in the promoter regions of extracellular matrix genes (58) . This mechanism appears to be operative in vivo also, because diacylglycerol mass and protein kinase C activity are also increased in glomeruli from diabetic rats and in isolated normal glomeruli acutely exposed to high glucose concentrations (59) . Since the change in diacylglycerol formation is through an enhanced de novo synthesis from glycolytic intermediates (19, 21, 57) in a process favored by the altered cellular redox state caused by the increased polyol pathway activity, it follows that the stimulation of extracellular matrix synthesis requires the accelerated metabolism of glucose.
Our studies in transduced cells demonstrate that glucose transport is an important modulator in MCs for glucose utilization and for the glucose effects on extracellular matrix metabo-lism. In addition, the glucose-stimulated rate of extracellular matrix accumulation appears to depend to a greater degree on the capacity to transport glucose than on the actual extracellular concentration of the hexose. This underlines the potential importance of the regulation of GLUTI expression and activity in MCs as a determinant of extracellular matrix deposition and mesangial expansion. Glucose flux via GLUT transporters may be regulated at the transcriptional level or by altering the rates of protein synthesis and degradation, changes in intrinsic activity, and the translocation of a vesicle-associated intracellular pool of transporters to the plasma membrane (26) . The latter, while being paramount in the GLUT4 activation by insulin, is of lesser importance for GLUTI-mediated transport due to the already preponderant localization of this isoform on the plasma membrane under basal conditions and its lesser translocation efficiency (60) . A large variety of agents regulate GLUTI expression (27) . In endothelial cells and hepatocytes hypoxia and inhibition of oxidative phosphorylation induce GLUTI expression (61, 62) . The most commonly reported effects of glucose have been those caused by its deprivation in both insulin-responsive and insulin-nonresponsive cells. These consist of changes in the transport of the hexose in association with increased GLUTi protein, with or without associated changes in GLUTI mRNA (25) . These effects are readily reversed by providing glucose. In contrast, in the adipose tissue and skeletal muscle of hyperglycemic animals with streptozotocin-induced diabetes, GLUTI mRNA and GLUTI protein are inappropriately unaffected (25, 63) .
The regulation of GLUTI expression by growth factors is of particular importance as a potential element in the pathogenesis of diabetic mesangial expansion. PDGF and TGF-P are known to enhance glucose uptake, increase GLUTI mRNA and promote GLUTI expression in cultures of fibroblast cell lines (64) (65) (66) (67) (68) . MCs, in turn, produce PDGF and TGF-/3 (67-70), thus having an autocrine system capable of regulating GLUTI expression. This system may be activated in diabetes because high glucose concentrations increase the MC secretion of TGFf3 and the expression of specific cellular receptors for this growth factor (71, 72) . Furthermore, MCs respond to the same growth factors by increasing extracellular matrix formation in vitro (72, 73 ) and by inducing mesangial expansion and glomerulosclerosis in vivo (74, 75) , but it is not known if GLUTI overexpression participates in the mediation of this effect.
It is of interest that oral hypoglycemic agents, extensively used in the treatment of Type II diabetes, are highly effective in increasing GLUTI expression and glucose transport. Metformin and the sulfonylureas tolbutamide and tolazamide increase GLUTI protein, GLUTI mRNA, and the translocation of this transporter to the plasma membrane in L6 myotubes and 3T3-L1 adipocytes (76) (77) (78) (79) . The relative effect of metformin is particularly intense in conditions of high glucose concentrations (76) . The relevance of these observations is tempered by the caution about extrapolating results in vitro with mechanisms in vivo. It could be speculated that the administration of these agents may result in the paradoxical circumstance in which an improvement in glycemia may be associated with greater glucose uptake and higher risk for the development of complications in GLUTl-expressing tissues. Whether this may occur in MCs is uncertain. There are many known examples of the tissue-specific regulation and expression of individual GLUT isoforms (26, 80) , and there is no present knowledge as to how this may proceed in MCs.
This work suggests that increased glucose uptake, rather than the level of glycemia per se, may be a major metabolic determinant in the development of mesangial expansion and glomerulosclerosis in diabetes. If MC GLUT1 expression and activity varies in human diabetes, this could explain the obscure predisposition of only a limited group of patients to the development of renal disease and the poor correlation between glycemic levels and progression of nephropathy in some of these cases, even after long periods of diabetes (81) .
